| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
CytoMed Therapeutics Ltd
13G
GDTC · Y1R80M106
|
7.6% |
3/4/2025
Event 2/17/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.